BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 16387467)

  • 1. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer.
    Rietman JS; Geertzen JH; Hoekstra HJ; Baas P; Dolsma WV; de Vries J; Groothoff JW; Eisma WH; Dijkstra PU
    Eur J Surg Oncol; 2006 Mar; 32(2):148-52. PubMed ID: 16387467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
    Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term morbidity of the upper limb after sentinel lymph node biopsy or axillary lymph node dissection for Stage I or II breast carcinoma.
    Rietman JS; Dijkstra PU; Geertzen JH; Baas P; De Vries J; Dolsma W; Groothoff JW; Eisma WH; Hoekstra HJ
    Cancer; 2003 Aug; 98(4):690-6. PubMed ID: 12910511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
    Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
    Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
    Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
    Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
    Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel node biopsy and quality of life measures in a Chinese population.
    Chen JJ; Huang XY; Liu ZB; Chen TW; Cheng JY; Yang WT; Xu WP; Shao ZM; Shen ZZ; Wu J
    Eur J Surg Oncol; 2009 Sep; 35(9):921-7. PubMed ID: 19233602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.
    Kootstra JJ; Dijkstra PU; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ; Hoekstra-Weebers JE
    Breast Cancer Res Treat; 2013 May; 139(1):125-34. PubMed ID: 23588950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
    Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
    Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.
    Purushotham AD; Upponi S; Klevesath MB; Bobrow L; Millar K; Myles JP; Duffy SW
    J Clin Oncol; 2005 Jul; 23(19):4312-21. PubMed ID: 15994144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures.
    Sagen A; Kaaresen R; Sandvik L; Thune I; Risberg MA
    Arch Phys Med Rehabil; 2014 May; 95(5):875-81. PubMed ID: 24389401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of upper limb function after axillary dissection.
    Gosselink R; Rouffaer L; Vanhelden P; Piot W; Troosters T; Christiaens MR
    J Surg Oncol; 2003 Aug; 83(4):204-11. PubMed ID: 12884231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between morbidity after axillary surgery and long-term quality of life in breast cancer patients: the role of anxiety.
    Aerts PD; De Vries J; Van der Steeg AF; Roukema JA
    Eur J Surg Oncol; 2011 Apr; 37(4):344-9. PubMed ID: 21296542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairments, disabilities and health related quality of life after treatment for breast cancer: a follow-up study 2.7 years after surgery.
    Rietman JS; Dijkstra PU; Debreczeni R; Geertzen JH; Robinson DP; De Vries J
    Disabil Rehabil; 2004 Jan; 26(2):78-84. PubMed ID: 14668143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early self-reported impairments in arm functioning of primary breast cancer patients predict late side effects of axillary lymph node dissection: results from a population-based cohort study.
    Albert US; Koller M; Kopp I; Lorenz W; Schulz KD; Wagner U
    Breast Cancer Res Treat; 2006 Dec; 100(3):285-92. PubMed ID: 16710790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer.
    Barranger E; Dubernard G; Fleurence J; Antoine M; Darai E; Uzan S
    J Surg Oncol; 2005 Oct; 92(1):17-22. PubMed ID: 16180226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
    Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
    Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.